Key Takeaways
- • The CFTC told a federal court that CME lacks standing to sue over its May approval of Kalshi's Bitcoin perpetual futures product, arguing CME has suffered no concrete harm.
- • The CFTC contends that trading volume in CME's own crypto futures products has risen since the Kalshi approval, undercutting CME's injury claim.
- • CME's core legal argument is that the Kalshi product is a swap rather than a futures contract, a classification the CFTC disputes in the context of the standing question.
- • TD Cowen analyst Jaret Seiberg warns the dispute could become more complicated if the perpetual futures market expands while the lawsuit is pending.
Summary
The U.S. Commodity Futures Trading Commission (CFTC) has filed a brief arguing that CME Group lacks standing to sue over the agency's approval of a cryptocurrency perpetual futures product, according to CoinDesk, which reported the filing on October 19, 2026.
The CFTC approved prediction-market platform Kalshi's Bitcoin (BTC) perpetual futures product in May. CME subsequently sued, arguing that the product is a swap rather than a futures contract. The CFTC disputed that characterization in its brief, asserting that CME had not suffered any concrete harm from the approval. The agency further pointed to rising trading volume in CME's own crypto futures products since the Kalshi listing as evidence that the exchange has not been materially injured.
The filing frames the case as one of legal standing rather than the merits of the product classification. Jaret Seiberg, an analyst at TD Cowen, said the situation could become more complicated if the perpetual futures market expands while the lawsuit is pending, since a growing market could alter the competitive picture that the CFTC currently describes as favorable to CME.
The case bears on how U.S. regulators classify perpetual contracts, a product type that has drawn growing attention from traditional derivatives exchanges and crypto-native venues alike. The outcome could influence whether similar products are treated as futures or swaps under existing oversight frameworks.
The CFTC approved prediction-market platform Kalshi's Bitcoin (BTC) perpetual futures product in May. CME subsequently sued, arguing that the product is a swap rather than a futures contract. The CFTC disputed that characterization in its brief, asserting that CME had not suffered any concrete harm from the approval. The agency further pointed to rising trading volume in CME's own crypto futures products since the Kalshi listing as evidence that the exchange has not been materially injured.
The filing frames the case as one of legal standing rather than the merits of the product classification. Jaret Seiberg, an analyst at TD Cowen, said the situation could become more complicated if the perpetual futures market expands while the lawsuit is pending, since a growing market could alter the competitive picture that the CFTC currently describes as favorable to CME.
The case bears on how U.S. regulators classify perpetual contracts, a product type that has drawn growing attention from traditional derivatives exchanges and crypto-native venues alike. The outcome could influence whether similar products are treated as futures or swaps under existing oversight frameworks.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.